Globus Medical Total Assets 2010-2022 | GMED

Globus Medical total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Globus Medical total assets for the quarter ending September 30, 2022 were $1.977B, a 3.45% increase year-over-year.
  • Globus Medical total assets for 2021 were $1.957B, a 16.54% increase from 2020.
  • Globus Medical total assets for 2020 were $1.679B, a 9.62% increase from 2019.
  • Globus Medical total assets for 2019 were $1.532B, a 17.79% increase from 2018.
Globus Medical Annual Total Assets
(Millions of US $)
2021 $1,957
2020 $1,679
2019 $1,532
2018 $1,301
2017 $1,079
2016 $928
2015 $834
2014 $704
2013 $566
2012 $447
2011 $329
2010 $267
2009 $0
Globus Medical Quarterly Total Assets
(Millions of US $)
2022-09-30 $1,977
2022-06-30 $1,915
2022-03-31 $1,999
2021-12-31 $1,957
2021-09-30 $1,911
2021-06-30 $1,830
2021-03-31 $1,738
2020-12-31 $1,679
2020-09-30 $1,542
2020-06-30 $1,466
2020-03-31 $1,479
2019-12-31 $1,532
2019-09-30 $1,452
2019-06-30 $1,391
2019-03-31 $1,336
2018-12-31 $1,301
2018-09-30 $1,239
2018-06-30 $1,194
2018-03-31 $1,128
2017-12-31 $1,079
2017-09-30 $1,037
2017-06-30 $995
2017-03-31 $960
2016-12-31 $928
2016-09-30 $902
2016-06-30 $869
2016-03-31 $840
2015-12-31 $834
2015-09-30 $801
2015-06-30 $765
2015-03-31 $744
2014-12-31 $704
2014-09-30 $646
2014-06-30 $618
2014-03-31 $599
2013-12-31 $566
2013-09-30 $525
2013-06-30 $498
2013-03-31 $474
2012-12-31 $447
2012-09-30 $416
2012-06-30 $367
2012-03-31 $355
2011-12-31 $329
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $267
2009-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.103B $0.958B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Edwards Lifesciences (EW) United States $46.932B 32.30
Alcon (ALC) Switzerland $33.321B 28.69
STERIS (STE) Ireland $18.019B 22.42
Teleflex (TFX) United States $10.587B 17.18
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Integer Holdings (ITGR) United States $2.367B 19.00
Glaukos (GKOS) United States $2.263B 0.00
Nevro (NVRO) United States $1.556B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00